Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|July 21, 2010
Ontologies of drug discovery and design for neurology, cardiology and oncologyJosé M Vázquez-Naya, Marcos Martínez-Romero, Ana B Porto-Pazos, et al.
Future Oncology (London, England)|June 21, 2014
Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancerMoisés Blanco-Calvo, Nuria Tarrío, Margarita Reboredo, et al.
Advances in Experimental Medicine and Biology|May 24, 2008
In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancerManuel Valladares Ayerbes, Silvia Díaz-Prado, Daniel Ayude, et al.
The Oncologist|February 25, 2012
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group StudyJavier Sastre, Cristina Grávalos, Fernando Rivera, et al.
Investigational New Drugs|February 4, 2010
A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimensJaafar Bennouna, Istvan Lang, Manuel Valladares-Ayerbes, et al.
Melanoma Research|July 18, 2006
Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanomaMargarita García, Xavier García del Muro, Alejandro Tres, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2009
Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot studyManuel Valladares-Ayerbes, Pilar Iglesias-Díaz, Silvia Díaz-Prado, et al.
Journal of Cancer Research and Therapeutics|June 24, 2017
Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine/nab-paclitaxel: Results of a retrospective analysisAna Fernández Montes, Paula González Villarroel, Manuel Valladares Ayerbes, et al.
Nutrients|January 8, 2025
Muscle Biomarkers in Colorectal Cancer Outpatients: Agreement Between Computed Tomography, Bioelectrical Impedance Analysis, and Nutritional UltrasoundAndrés Jiménez-Sánchez, María Elisa Soriano-Redondo, María Del Carmen Roque-Cuéllar, et al.
Journal of Gastrointestinal Oncology|July 17, 2025
The diagnostic efficiency of tissue factor pathway inhibitor 2 methylation in the detection of colorectal cancer: a systematic review and meta-analysisXiao-Ling Wang, Shuo Qin, Li Liu, et al.
Pageof 7